WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia
6 December 2021
| Guideline
Overview
In 2019, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. This decision was based on new evidence on the subject that had become available. The recommendation in this document thus supersedes the previous WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia as published in the 2011 guidelines, WHO recommendations for the prevention and treatment of pre-eclampsia and eclampsiaRelated publications - 2020 UPDATES
WHO recommendations on drug treatment for non-severe hypertension in pregnancy
Related publications - 2018 UPDATES
Drug treatment for severe hypertension in pregnancy
2 recommendations, 75 pages
Policy of interventionist versus expectant management of severe pre-eclampsia before term
3 recommendations, 31 pages
Calcium supplementation during pregnancy for prevention of pre-eclampsia and its complications
1 recommendation, 44 pages
WHO Team
Guidelines Review Committee,
Maternal, Newborn, Child & Adolescent Health & Ageing (MCA),
Sexual and Reproductive Health and Research (SRH)
Editors
World Health Organization
Number of pages
78
Reference numbers
ISBN: 978 92 4 003754 0